With the French Regulatory Approval by ANSM, the clinical trial is fully approved in 15 countries The clinical trial with once a day oral dosing is being conducted in 232 patients with moderate to severe ulcerative colitis in about 150 study sites As announced during...
The STEADFAST clinical study of TX200 is the first-in-human trial to evaluate a CAR-Treg cell therapy BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the United Kingdom’s (UK)...
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Range of VK2809 Doses for up to 52 Weeks SAN DIEGO, Nov. 19, 2019 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on...
Westport, CT, Nov. 21, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full...
COPE-WEL study aims to validate Headstart® test for early detection and monitoring of pulmonary exacerbation of COPD • Headstart is a non-invasive self-test that detects lung biomarkers in the urine • Observational, multi-centre validation trial carried out in...
HOPKINTON, Mass., Nov. 20, 2019 (GLOBE NEWSWIRE) — Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today...
Email
Text